lilypily: "Also highlights how big the difference is in biotech land valuation of the Nasdaq and ASX"
You are so correct, lilypily! JIMHO: The ASX undervalues the really promising Australian listed biotechs probably by more than 50%. Which, however, can be seen as an opportunity to buy into promising stocks cheaply - IF the assumption would/will be correct that the final validation of what is 'at hand' in a take-over situation will get a lot closer to an American one?! Comments most welcome as usual.
Happy to hold onto all my NEU shares - did even add a few not too long ago !
wasa
Add to My Watchlist
What is My Watchlist?
